University of North Carolina School of Medicine
333 South Columbia Street
Chapel Hill, North Carolina 27599

Use our guide to learn which trials are right for you!

We've found
8 trials
at this facility
Pulmonary / Respiratory Diseases, Rheumatology Clinical Trial
Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis
Status: Enrolling
Updated: 6/23/2005
University of North Carolina School of Medicine
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of North Carolina School of Medicine
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Sickle Cell Anemia Clinical Trial
Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia
Status: Enrolling, Phase I, II
Updated: 6/23/2005
University of North Carolina School of Medicine
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Barrett Esophagus Clinical Trial
Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System
Status: Enrolling
Updated: 12/31/1969
University of North Carolina School of Medicine
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Respiratory Distress Syndrome, Adult Clinical Trial
Evaluation of Safety & Efficacy of BIO-11006 Inhalation Solution in Patients With ARDS
Status: Enrolling, Phase II
Updated: 12/31/1969
University of North Carolina School of Medicine
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Primary Pulmonary Hypertension Clinical Trial
Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil
Status: Enrolling, Phase III
Updated: 12/31/1969
University of North Carolina School of Medicine
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
Inhaled Oxytocin and HPA Axis Reactivity
Status: Enrolling, Phase II
Updated: 12/31/1969
University of North Carolina School of Medicine
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Oncology Clinical Trial
NBTXR3 Activated by SABR for Patients With Advanced HNSCC or NSCLC Treated With an Anti-PD1 Antibody
Status: Upcoming, Phase I, II
Updated: 12/31/1969
University of North Carolina School of Medicine
mi
from
Chapel Hill, NC
Click here to add this to my saved trials